Injection-Molded Hydrogel Macroencapsulation for Oxygen Diffusion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current macroencapsulation devices for islet cell transplantation face challenges in oxygen diffusion and immunosuppressive drug regimens, limiting their efficacy and widespread applicability due to non-ideal device geometry and specialized fabrication requirements.
Innovation Solution
A hydrogel macroencapsulation device with optimized geometry, fabricated using an injection mold, that minimizes oxygen diffusion distances and allows for bedside implementation, utilizing biocompatible hydrogels with bioorthogonal reactive groups and a multi-component injection mold device.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional hydrogel microcapsules are used for islet encapsulation, then immune isolation is achieved, but safety limitations arise due to non-retrievability and adhesion to internal organs
Solution Approach 1:
The invention transitions from microcapsule-scale isolation to macroencapsulation device-scale isolation, segmenting the approach from individual capsule isolation to structured device isolation with controlled geometry and retrieval mechanisms
Solution Approach 2:
Instead of accepting non-retrievability as inevitable with microcapsules, the invention designs macroencapsulation devices with intentional retrieval capabilities, inverting the problem from 'how to prevent adhesion' to 'how to enable controlled retrieval'
2Reliability
If macroencapsulation devices with complex 3D geometries are fabricated using traditional methods, then optimal oxygen diffusion is achieved, but fabrication complexity and specialized equipment requirements increase
Solution Approach 1:
The invention replaces complex traditional fabrication mechanical systems with injection molding technology, which uses standardized mechanical injection processes to create complex 3D geometries that optimize oxygen diffusion while simplifying the overall fabrication approach
Solution Approach 2:
The invention changes the fabrication parameter space by adopting injection molding parameters (temperature, pressure, injection rate) that enable complex geometry fabrication with standard equipment, rather than requiring specialized fabrication parameters and equipment
3Reliability
If macroencapsulation devices are designed with optimized geometry for oxygen diffusion, then cell viability improves, but manufacturing precision requirements increase
Solution Approach 1:
Injection molding replaces less precise traditional fabrication methods with a process that inherently provides better geometric precision through mold-based formation, ensuring consistent oxygen diffusion pathways while maintaining manufacturing feasibility
Solution Approach 2:
The geometric precision is built into the injection mold design itself before fabrication begins, with oxygen diffusion-optimized geometries pre-programmed into the mold cavities, eliminating the need for post-fabrication precision adjustments
4Manufacturing precision
If specialized assembly equipment and expertise are required for macroencapsulation device fabrication, then fabrication precision can be maintained, but ease of operation and clinical accessibility decrease
Solution Approach 1:
The invention replaces specialized assembly equipment with standard injection molding equipment that is more widely available in clinical settings, maintaining fabrication precision through the mold-based process while significantly improving ease of operation and accessibility
Solution Approach 2:
The injection molding process is designed to be self-contained and relatively simple to operate, reducing the need for highly specialized expertise and enabling broader clinical adoption without sacrificing fabrication quality
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution provides enhanced oxygenation and cell viability, enabling transplantation in various sites without immunosuppression, and facilitates easy fabrication and scalability in clinical settings.
Implementation Method 1
a biocompatible hydrogel operable to be crosslinked within an injection mold
Implementation Method 2
the diffusion of sufficient oxygen within the device to support encapsulated cell survival
Data Source
AI summary
Provided herein is a cell macroencapsulation device composed of hydrogel in a 3D conformation that optimizes encapsulated cell viability and function when transplanted into a vascularized tissue space. The hydrogel macroencapsulation device is intended to reduce or eliminate immune response to the cell graft, while allowing exchange of encapsulated cell-secreted products, such as insulin. Also described herein is an injection-mold and fabrication process to generate the hydrogel macroencapsulation devices for use in the clinic.